AT

Alphatec Holdings, Inc.

ATECHealthcareNASDAQ

Medical Devices

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$764.2M
+25.0% YoY
Net Income
-$143.4M
+11.6% YoY
EBITDA
-$14.9M
+72.3% YoY
Free Cash Flow
$48.3M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 20 MACD Negative CrossoverHistogram -0.0060, negative momentum
Aug 19 MACD Negative CrossoverHistogram -0.0126, negative momentum
About Alphatec Holdings, Inc.

Headquartered within the healthcare sector, Alphatec Holdings, Inc. focuses on Medical Devices services and products. Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. At a $1.46B market cap, Alphatec Holdings, Inc. ranks as a small-cap company within healthcare. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.

Where ATEC stands vs its 150-day and 200-day moving averages

As of the August 20, 2026 close, ATEC finished 9.22% below its 150-day moving average ($10.74) and 26.02% below its 200-day moving average ($13.18). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ATEC overbought or oversold?

At the August 20, 2026 close, ATEC's RSI(14) was 51.3, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.46B
Fwd P/E15.77
EPS$-0.71
Beta0.85
52W Change-42.2%
ROE-373.4%
Analysis

Alphatec Holdings, Inc. carries $604.0M in total debt against $118.7M in cash reserves — debt is roughly 5.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $48.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -373.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $243.2M (2021) to $764.2M (2025), reflecting a 214% increase over the period.

Alphatec Holdings, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing ATEC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms